Problems related to the application of guidelines in clinical practice: A critical analysis

Hellenic Journal of Cardiology

Volumn 52, Issue 2, 2011, Pages 97-102

  Geleris, Paraschos ^a   Boudoulas, Harisios ^b,c  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

Clinical experience; Guidelines; Individualised medicine; Prospective studies

Indexed keywords

ACETYLSALICYLIC ACID; CHOLESTEROL; CLOPIDOGREL; CREATININE; GLUCOSE; PLACEBO; PROTON PUMP INHIBITOR;

BLOOD GLUCOSE MONITORING; CHOLESTEROL BLOOD LEVEL; COLONOSCOPY; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DRUG EFFECT; EDITORIAL; GLUCOSE BLOOD LEVEL; HEALTH CARE DISPARITY; HEART ARRHYTHMIA; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; ISCHEMIA; KIDNEY FAILURE; META ANALYSIS (TOPIC); MORTALITY; PERSONALIZED MEDICINE; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PROFESSIONAL PRACTICE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY FAILURE; SUDDEN DEATH;

CLINICAL MEDICINE; GUIDELINE ADHERENCE; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC;

EID: 79955147020     PISSN: 10117970     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (32)

1. Lewis WR, Peterson ED, Cannon CP, et al. An organized approach to improvement in guideline adherence for acute myocardial infarction: results with the Get With The Guidelines quality improvement program. Arch Intern Med. 2008; 168: 1813-1819.
2. Xian Y, Pan W, Peterson ED, et al. Are quality improvements associated with the Get With the Guidelines-Coronary Artery Disease (GWTG-CAD) program sustained over time? A longitudinal comparison of GWTG-CAD hospitals versus non-GWTG-CAD hospitals. Am Heart J. 2010; 159: 207-214.
3. Vardas PE. Implementation of ESC guidelines: is it primarily a scientific, political, or financial matter? Hellenic J Cardiol. 2010; 51: 193-194.
4. DeMaria AN. Clinical trials and clinical judgment. J Am Coll Cardiol. 2008; 51: 1120-1122.
5. Shaneyfelt TM, Mayo-Smith MF, Rothwangl J. Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical literature. JAMA. 1999; 281: 1900-1905.
6. Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989; 321: 406-412.
7. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The SOLVD Investigators. N Engl J Med. 1992; 327: 685-691.
8. Boden WE, O'Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007; 356: 1503-1516.
9. McAlister FA, Van Diepen S, Padwal RS, Johnson JA, Majumdar SR. How evidence-based are the recommendations in evidence-based guidelines? PLoS Med. 2007; 4: e250.
10. Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA. 2005; 294: 716-724.
11. Ho PM, Maddox TM, Wang L, et al. Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome. JAMA. 2009; 301: 937-944.
12. Rennie D, Chalmers I. Assessing authority. JAMA. 2009; 301: 1819-1821.
13. ISIS 2 Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988; 2: 349-360.
14. Bourgeois FT, Murthy S, Mandl KD. Outcome reporting among drug trials registered in ClinicalTrials.gov. Ann Intern Med. 2010; 153: 158-166.
15. Weissler AM, Miller BI, Boudoulas H. The need for clarification of percent risk reduction data in clinical cardiovascular trial reports. J Am Coll Cardiol. 1989; 13: 764-766.
16. Tricoci P, Allen JM, Kramer JM, Califf RM, Smith SC. Scientific evidence underlying the ACC/AHA clinical practice guidelines. JAMA. 2009; 301: 831-841.
17. The European Society of Cardiology Practice Guidelines discussed by Professor Alec Vahanian, Chairman of the ESC's Committee for Practice Guidelines. Eur Heart J. 2009; 30: 2415-2416.
18. Shekelle PG, Ortiz E, Rhodes S, et al. Validity of the Agency for Healthcare Research and Quality clinical practice guidelines: how quickly do guidelines become outdates? JAMA. 2001; 286: 1461-1467.
19. Wooley CF, Boudoulas H. Clinician. Hellenic J Cardiol. 1993; 34: 241-243.
20. Wooley CF, Sparks EA, Olsen S, Boudoulas H. A cardiovascular teaching laboratory: the master class in ambulatory teaching. Hellenic J Cardiol. 2008; 48: 7-16.
21. Ganotakis ES, Mikhailidis DP, Vardas PE. Atrial fibrillation, inflammation and statins. Hellenic J Cardiol. 2006; 47: 51-53.
22. King SB, Lembo NJ, Weintraub WS, et al. A randomized trial comparing coronary angioplasty with coronary bypass surgery. Emory Angioplasty versus Surgery Trial (EAST). N Engl J Med. 1994; 331: 1044-1050.
23. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. N Engl J Med. 1996; 335: 217-225.
24. Pereira AC, Lopes NHM, Soares PR, et al. Clinical judgment and treatment options in stable multivessel coronary artery disease: results from the one-year follow-up of the MASS II (Medicine, Angioplasty, or Surgery Study II). J Am Coll Cardiol. 2006; 48: 948-953.
25. Shaneyfelt TM, Centor RM. Reassessment of clinical practice guidelines: go gently into that good night. JAMA. 2009; 301: 868-869.
26. Stakos D, Boudoulas H. Pharmacogenetics and pharmacogenomics in cardiology. Hellenic J Cardiol. 2002; 43: 1-15.
27. Boudoulas H. There is no substitute for talent. Hellenic J Cardiol. 2005; 46: 375.
28. Choudhry NK, Stelfox HT, Detsky AS. Relationships between authors of clinical practice guidelines and the pharmaceutical industry. JAMA. 2002; 287: 612-617.
29. Luce BR, Kramer JM, Goodman SN, et al. Rethinking randomized clinical trials for comparative effectiveness research: the need for transformational change. Ann Intern Med. 2009; 151: 206-209.
30. Ting HH, Shojania KG, Montori VM, Bradley EH. Quality improvement: science and action. Circulation. 2009; 119: 1962-1974.
31. Boudoulas H. The well-rounded clinician. Hellenic J Cardiol. 2005; 46: 317.
32. Boudoulas H. Medical error in clinical practice. Hellenic J Cardiol. 2006; 47: 129-130.